Neonatal treatments.

a<p>Percentages given according to available data.</p>b<p>Mean treatment length calculated for neonates receiving each antibiotic.</p>c<p>Mean difference with 95% CI.</p>d<p>Mean treatment length calculated from neonates receiving each treatment.</p><p>NA, not applicable; SD, standard deviation.</p

Meta-analysis.

<p>Risk ratio according to Mantel-Haenszel (M–H) with fixed effects and 95% CIs for neonatal sepsis, culture-proven neonatal sepsis, RDS, and cesarean section rates.</p

Trial profile.

<p>Trial profile.</p

Maternal outcomes.

<p>Data are presented as number (percent).</p>a<p>Percents, RRs, 95% CIs, and <i>p</i>-values given are related to available data per characteristic and may differ from the total number of patients.</p>b<p>Outcome characteristic with more than 5% missing data. Histological chorioamnionitis data available for 396 women (74%); histological funisitis data available for 388 women (73%).</p

Stepwise procedure of CS quality indicator development.

<p>Stepwise procedure of CS quality indicator development.</p

Baseline characteristics.

<p>Data are presented as number (percent) unless otherwise indicated.</p>a<p>Percents given are related to available data per characteristic and may differ from total number of patients.</p>b<p>Percents given as part of known educational level.</p>c<p>Outcome characteristic with more than 5% missing data. Education: data available for 310 women (58%); body mass index at booking: data available for 453 women (85%); body mass index at start study available for 266 women (50%); maternal temperature at inclusion: data available for 504 women (95%).</p>d<p>Sum of tests exceeds 100% because more than one test could be applied on the same patient.</p><p>IQR, interquartile range; PAMG-1, placental alpha macroglobulin-1; ROM, rupture of membranes; SD, standard deviation.</p

Neonatal outcomes.

<p>Data are presented as number (percent) unless otherwise indicated.</p>a<p>Percentages, RRs, 95% CIs, and <i>p</i>-values given according to available data.</p>b<p>Outcome characteristic with more than 5% missing data. Neonatal temperature data available for 292 infants (54%); pH umbilical artery data available for 397 (74%); intraventricular hemorrhage data available for 508 (94%).</p>c<p>Mean difference with 95% CI.</p><p>HIE, hypoxic ischemic encephalopathy; IQR, interquartile range; IVH, intraventricular hemorrhage; NA, not applicable; PVL, periventricular leucomalacia; SD, standard deviation.</p

Baseline characteristics for randomized versus non-randomized participants.

<p>Data are presented as number (percent) unless otherwise indicated.</p>a<p>Percents given are related to available data per characteristic and may differ from the total number of patients.</p>b<p>Percents given as part of known educational level.</p>c<p>Outcome characteristic with more than 5% missing data. Education: data available for 425 women (58%); body mass index at booking: data available for 616 women (83%); body mass index at start study available for 346 women (47%); maternal temperature at inclusion: data available for 689 women (93%).</p

Kaplan-Meier curve for the interval between randomization and birth.

<p>Kaplan-Meier curve for the interval between randomization and birth.</p